[{"_1":2,"_110":-5,"_111":-5},"loaderData",{"_3":4,"_26":27},"root",{"_5":6,"_17":10,"_18":19,"_20":21,"_22":10,"_23":-5,"_24":-5,"_25":10},"user",{"_7":8,"_9":10,"_11":10,"_12":-5,"_13":-5,"_14":15,"_16":-5},"roles",[],"isAuthenticated",false,"isPremium","planName","subscriptionStatus","featureFlags",{},"insightsBudget","isDevelopmentHost","userPreferences",{},"recaptchaSiteKey","6LcvOJcUAAAAAHsB-gPGfGktcRlKpH7OTIU_dMTD","isImpersonating","impersonation","affiliateStatus","isFreedomPortal","routes/v2/article/layout",{"_28":29,"_30":31},"notFound",true,"relatedArticles",[32,74,86,98],{"_33":34,"_35":36,"_37":38,"_39":40,"_41":42,"_43":44,"_45":44,"_46":47,"_48":49,"_50":51,"_52":53,"_54":55,"_56":57,"_58":59,"_60":61,"_62":63,"_64":65,"_66":67,"_68":69,"_70":71,"_72":55,"_73":55},"mediaId",6241981,"mediaKeyId","3251513-f4162b15b96a5b3c3f2aafb45a9975d0","parentId",3251513,"title","Committee discusses telehealth recording and AI use; seeks clearer scope and testimony on H.84","audioSeconds",0,"startMs",4142000,"endMs","viewUrl","/Search/View?dp=1&key=3251513-f4162b15b96a5b3c3f2aafb45a9975d0&start=4142&end=4142","thumbnailUrl","https://assets.pipeline.soar.com/3251513-f4162b15b96a5b3c3f2aafb45a9975d0/thumbnail_4142000.jpg","articleUrl","/articles/6241981/Vermont/Committee-discusses-telehealth-recording-and-AI-use-seeks-clearer-scope-and-testimony-on-H84","mediaUrl","https://secure.pipeline.soar.com/6241981-4b00226cf0189ee7a7890225178aabf1/orig.mp4?Expires=1776144047&Signature=etyl6XL7hZCtUw~g65hlrjrptjh7qLqMhSRP8wW5m2WbZ~cu~dMgX4Fb8PMgyJeQEIRPgREKpcZysrrDNxEJHHfIa9WsfgR7f1DTJvBXYbyjol55YmiX-Mgu3Hl-YdXY0r7zsDFArrsUoWUSIyjpyS2BqRkXvcgr1lZjWJ3Fbvjrq0k9~fMx~Jqx6xhxDywqfk-ji9cLbnvDJXdZRPCQ89sqIG0VFILmYNMTtn3tZpe9wzSnx0zRCPoohby72cbFJy85CusCtmG9XWpJmHkzHyvmaTEh3PB6wXEZfnTIiEVGZl1xEih9AWJ7bRotIzN8Y5gK8MlZQRo9Nfdk-DZR0w__&Key-Pair-Id=KUT5TJCACFTXG","author","","date","2025-05-09T14:50:32Z","article","The Health Care committee revisited telehealth recording and the use of artificial intelligence in medical records during its May 9 meeting, noting earlier walkthroughs and preliminary testimony on H.84.

Members recalled prior testimony about hospitals’ interest in recording telehealth encounters for AI purposes and asked for a focused hearing on permission, consent and the intended downstream uses of recordings. One member noted hospitals asked to delay the bill this year and preferred testimony next year; others said a short‑term hearing could clarify recording consent and the interplay with AI tools.

The committee discussed narrow approaches such as clarifying when recordings require patient permission, what safeguards apply to AI‑derived outputs and whether recordings used for training or clinical decision support need distinct privacy protections. Staff were asked to check prior testimony and ascertain whether additional witnesses (hospitals, patient advocates and privacy experts) could present during interim work.

No policy was adopted at the meeting; members requested follow‑up testimony and documentation of prior hearings on H.84.","mediaType","Video","parentTitle","House Healthcare - 2025-05-09 - 10:50 AM","oneSentenceSummary","Members reviewed prior walkthroughs and earlier testimony on H.84, the telehealth recording bill, and discussed concerns about recording, consent and downstream AI use in medical records.","taxTitle","Health Care, HOUSE OF REPRESENTATIVES, Committees, Legislative , Vermont","taxId",30956,"location","Vermont","headline","shortSummary",{"_33":75,"_35":36,"_37":38,"_39":76,"_41":77,"_43":78,"_45":79,"_46":80,"_48":81,"_50":82,"_52":83,"_54":55,"_56":57,"_58":84,"_60":61,"_62":63,"_64":85,"_66":67,"_68":69,"_70":71,"_72":55,"_73":55},6241987,"Committee hears calls for oversight of youth psychotropic prescriptions and expanded school mental‑health supports",175,3580000,3755000,"/Search/View?dp=1&key=3251513-f4162b15b96a5b3c3f2aafb45a9975d0&start=3580&end=3755","https://assets.pipeline.soar.com/3251513-f4162b15b96a5b3c3f2aafb45a9975d0/thumbnail_3580000.jpg","/articles/6241987/Vermont/Committee-hears-calls-for-oversight-of-youth-psychotropic-prescriptions-and-expanded-school-mentalhealth-supports","https://secure.pipeline.soar.com/6241987-9e1388256a0b9bc56d9ce98b62349179/orig.mp4?Expires=1776144047&Signature=UB9V7XndXSpvCqfSfB1VDaeKhYGGanm7~GwUFKSgw5mToOvkF~TvEP5xKYh019gcgQ74v8m24l2MblKPT8q6rju9ahmnUsUEQhkv6-BaVej2tcd1xcQ3jF1UAQgExuyxuQFVHbXogIH2c0fSL2Oig7G3T3y~R7Kls5nqzaYRBZGz1fH5kayAOOihY9Ep~clSf-jp7VtOhi1vqyP8ej4FG9kfT-7NUK26E78EjOISn~~ONs~Iic6aIylzw670wEhdRApyYVW3qYGYv3k~YN7WEreylhF3wp3eNw7G-IW-MWEGkIjv8vdEzTNVM1-ZOLJuJMfT8cWHS~ciCPO7X0uZFA__&Key-Pair-Id=KUT5TJCACFTXG","The Health Care committee discussed several youth mental health proposals May 9, including improved reporting and oversight of psychotropic medications for children and expansion of school‑based and peer‑led services.

Members said statewide data flagged a substantial number of children receiving psychotropic medications and asked for better reporting and protections for young patients. A committee member said national monitoring had raised alarms when Vermont’s counts appeared in the data; the member asked the Office of the Health Care Advocate and other agencies to help assemble better reporting and oversight information.

Committee members singled out several bills for summer work: a short‑form bill (H.305) to increase oversight of psychotropic prescriptions in children and adolescents, and another proposal (listed in committee materials) to fund school‑based mental health programs and peer support through a mental health innovation special fund. Members described school‑based peer programs and trainings (for example, NAMI trainings) as potentially scalable elements to improve early intervention.

Members asked staff to line up testimony from the Office of the Health Care Advocate, clinicians, school representatives and youth‑focused advocates to clarify numbers, guardianship and consent issues, and potential reporting requirements. No committee action was taken at the meeting.","Committee members urged more oversight of youth psychotropic prescribing after data showed thousands of children receiving off‑label medications and asked to hear testimony on school‑based mental health, peer support programs and mental health innovation funding.",{"_33":87,"_35":36,"_37":38,"_39":88,"_41":89,"_43":90,"_45":91,"_46":92,"_48":93,"_50":94,"_52":95,"_54":55,"_56":57,"_58":96,"_60":61,"_62":63,"_64":97,"_66":67,"_68":69,"_70":71,"_72":55,"_73":55},6241991,"Committee flags questions about biomarker and genetic testing bill; members raise insurance and privacy concerns",1196,1638000,2834000,"/Search/View?dp=1&key=3251513-f4162b15b96a5b3c3f2aafb45a9975d0&start=1638&end=2834","https://assets.pipeline.soar.com/3251513-f4162b15b96a5b3c3f2aafb45a9975d0/thumbnail_1638000.jpg","/articles/6241991/Vermont/Committee-flags-questions-about-biomarker-and-genetic-testing-bill-members-raise-insurance-and-privacy-concerns","https://secure.pipeline.soar.com/6241991-696d0a307c9fc28d22a699e6ac0ff737/orig.mp4?Expires=1776144047&Signature=a7s9QK0WDjGvYCJ1aubDMDNhSwuCx~SeJSiP1QElPCDZL-lxJjY9MItnwaMPlc1UHXTigULvMiBYMnna6BMXsFpHYtq8Ka2cKROuGJq9l7aouFl5YqjTupvrZboNVd~GZ8vxycOgRsNwuQyOgMOZKeCYGQs0l6T76-owu4ufqRN1Ku2z45zZ8YW1WYnclj1UMBFlDHSVMgGE76pNOr~axhl27p4GnQxHXgGT8Eryn-fFndGRUPykYulqesaTpa5BWV2~J~QwlNPGhBoG7iJ1QST2Sj5F1XOIMDdXhIYvg~oo4sYS41u6l3IoiGFqAa~PC4ogcqzuqqscj-xgfcYoKA__&Key-Pair-Id=KUT5TJCACFTXG","The Health Care committee discussed H.136 and the broader topic of biomarkers and genetic testing during its May 9 meeting, exploring both clinical benefits and potential policy risks.

Members said biomarkers could speed diagnosis for conditions such as certain autoimmune disorders, long COVID and hereditary risks, and that clinicians described examples where genetic information might change treatment. At the same time several members voiced concern about how insurers might use genetic information and about potential discrimination or coverage denial.

Committee members asked to schedule testimony to understand the bill’s scope and to hear from clinicians and patient advocates. Participants noted specific clinical examples discussed in the meeting, including genetic predispositions such as MTHFR mutations and the possible value of preemptive clinical interventions (for example, treating blood‑clot risk during COVID infection in people with certain genetic dispositions).

The group also raised procedural concerns: members requested clear explanations of what the bill would and would not require and how it would interact with existing insurance rules. Multiple members said they wanted more information on how biomarker testing would affect coverage decisions, privacy protections and whether federal or state law limits insurer use of genetic data.

Members asked staff to line up experts (clinicians, patient advocates, and privacy specialists) for a structured, evidence‑based hearing that would include examples of how biomarker results would change clinical care and the safeguards needed to protect patients. The committee did not take action on H.136 at the meeting.","Members of the Health Care committee discussed bill H.136 on biomarkers and genetic testing, including potential benefits for diagnosis and treatment, and concerns about insurance use, privacy and impacts on people with autoimmune conditions and long COVID.",{"_33":99,"_35":36,"_37":38,"_39":100,"_41":101,"_43":102,"_45":103,"_46":104,"_48":105,"_50":106,"_52":107,"_54":55,"_56":57,"_58":108,"_60":61,"_62":63,"_64":109,"_66":67,"_68":69,"_70":71,"_72":55,"_73":55},6241996,"Health Care committee presses for contingency plans as federal funding for Medicaid remains uncertain",590,262000,852000,"/Search/View?dp=1&key=3251513-f4162b15b96a5b3c3f2aafb45a9975d0&start=262&end=852","https://assets.pipeline.soar.com/3251513-f4162b15b96a5b3c3f2aafb45a9975d0/thumbnail_262000.jpg","/articles/6241996/Vermont/Health-Care-committee-presses-for-contingency-plans-as-federal-funding-for-Medicaid-remains-uncertain","https://secure.pipeline.soar.com/6241996-8ca2c93eb3b8a97b865f1fd40c093245/orig.mp4?Expires=1776144047&Signature=LFvJ56oCguhM-sSKMRNiCqbGncgC4XUkCtUZXCBrLAlZBdS1CR3vkAbQemRJWJoWAgNli5mHHx~3uPuwiyvBneIFzp0fwHNztrDXmNYzu5kVzIa6qv9TnfRNoEtFSo-uxusfeIO53BiRQ2u086HMFtgoqrA6ImJYs5Bdioz9hMdEUp7cRDgfXCQQafyXRhOqBcuJetuxWvNrSWM6fesJpOWjDTT1-HLUBrla8sgkx-egrYuG0VELzZFK~vvsp6gGZFcEl6R1Vn-ed2h5hCkDTuxmBO2y0VO5M8n508F8HqvLHCJQTg73sV89v-WJbTM4xXZqqk-jiGkA4SeQgTM8yA__&Key-Pair-Id=KUT5TJCACFTXG","Members of the Health Care committee met May 9 to discuss contingency planning for Medicaid and other programs as federal funding questions remain unresolved.

Committee members said the Joint Fiscal Office tracker and briefings from budget staff would help them explain impacts to constituents and decide whether the legislature must reconvene under budget trigger language. The meeting focused on how federal choices — including possible changes to enhanced premium tax credits and cost‑sharing reduction (CSR) policy and discussions about cuts to the provider tax — could affect state budgeting for Medicaid and related services.

Committee members asked staff for updated numbers and a short briefing they could share with constituents, and discussed asking the Joint Fiscal Office for an updated “tracker” of federal developments. Members also proposed inviting the treasurer and other officials to community forums or committee testimony to explore options for using state funds or reserves to shore up services.

Members highlighted two federal issues separately tracked in testimony: a potential loss in buying power for Vermonters if enhanced premium tax credits expire (an estimate discussed in the meeting attributed to “Deepa” put the loss at about $65,000,000 for Vermonters) and renewed federal guidance about CSR funding versus state “silver loading” approaches. The committee discussed a marketplace estimate that reversing prior state silver‑loading choices combined with federal changes could represent roughly $115,000,000 in impacts to Vermonters.

The group also discussed reporting in national press and informal analyses that reductions of the provider tax could cost Vermont between $250,000,000 and $500,000,000, depending on whether half or all of the provider tax were lost. Members framed that risk as a driver for caution about new state spending and for identifying contingency steps in the budget language that trigger fuller legislative involvement; committee members noted budget language with percentage triggers (for example, a 5% threshold that would require the full legislature to reconvene).

The committee agreed to pursue briefings (including a possible Joint Fiscal Office presentation), gather updated numbers and consider targeted testimony from affected providers and advocates. They also discussed tracking social drivers of health (food pantries, Head Start, rural maternal health) and how cuts outside Medicaid could indirectly raise health needs and costs.

The meeting did not adopt new spending or a formal policy change; members asked staff to prepare materials and testimony options for summer work and for potential reconvening if federal developments require it.

Ending — The committee set next steps: request updated JFO materials and budget language walk‑throughs, line up testimony from state fiscal and treasury staff and from community providers, and continue tracking federal developments over the summer.","Members of the Health Care committee on May 9 urged staff briefings and contingency planning after federal actions could reduce enhanced tax credits, cost‑sharing reductions and elements of Vermont’s provider tax that support Medicaid funding.","actionData","errors"]

Article not found

Committee discusses telehealth recording and AI use; seeks clearer scope and testimony on H.84

Committee hears calls for oversight of youth psychotropic prescriptions and expanded school mental‑health supports

Committee flags questions about biomarker and genetic testing bill; members raise insurance and privacy concerns

Health Care committee presses for contingency plans as federal funding for Medicaid remains uncertain